Menu Search
Equities

Zhengye Biotechnology Holding Ltd

ZYBT:NAQ

Zhengye Biotechnology Holding Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zhengye Biotechnology Holding Ltd is a China-based company mainly engaged in the research and development of veterinary vaccines. The Company's main business is the research, development, production, and sales of livestock vaccines. The Company's main products include monovalent vaccines, multivalent vaccines, combination vaccines and other biological medicine, which can be used to treat pigs, cows, goats, sheep, poultry and other animals. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market.

  • Revenue in -- (TTM)--
  • Net income in --
  • Incorporated2023
  • Employees--
  • Location
    Zhengye Biotechnology Holding LtdJILIN F4 132101ChinaCHN
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.